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Background: The prevalence and severity of asthma is believed to increase with increasing socioeco-
nomic deprivation. The relationship between asthma diagnosis, symptoms, diagnostic accuracy, and
socioeconomic deprivation as determined by Townsend scores was determined in Sheffield schoolchil-
dren.
Methods: All 6021 schoolchildren aged 8–9 years in one school year in Sheffield were given a par-
ent respondent survey based on International Survey of Asthma and Allergies in Childhood (ISAAC)
questions.
Results: 5011/6021 (83.2%) questionnaires were returned. Postcode data were available in 4131
replies (82.4%) and were used to assign a composite deprivation score (Townsend score). Scores were
divided into five quintiles, with group 1 being least and group 5 being most deprived. A positive trend
was observed from group 1 to group 5 for the prevalence of wheeze in the previous 12 months,
wheeze attacks >4/year, nocturnal wheeze and cough (all p<0.001), cough and/or wheeze “most
times” with exertion (p<0.03), current asthma (p<0.001), and significant asthma symptoms (p<0.001).
No significant trend was observed for lifetime wheeze or attacks of speech limiting wheeze. There were
no significant trends in the prevalence of current asthmatic children without significant symptoms (over-
diagnosis) or children with significant asthma symptoms but no current asthma diagnosis (underdiag-
nosis) across the social groups. There was a significant negative trend in the ratio of asthma medication
to asthma diagnosis from least to most deprived groups (p<0.001).
Conclusions: Asthma morbidity and severity increase according to the level of socioeconomic depri-
vation. This may be due to differences in environment, asthma management, and/or symptom report-
ing. Diagnostic accuracy does not vary significantly across deprivation groups but children living in
areas of least deprivation and taking asthma medication are less likely to be labelled as having
asthma, suggesting diagnostic labelling bias.
There are major inequalities in health between differentsocioeconomic groups. The prevalence and severity ofasthma and wheeze related illness in children has been
shown to increase with increasing deprivation measured
using various socioeconomic markers,1 and asthma mortality
for the age group 5–55 years has been found to increase with
worsening deprivation.2 The underlying mechanisms of these
associations have not been elucidated, as socioeconomic
factors may influence both symptomatology and behaviour
arising from symptoms, both in carers and in health workers.
We have examined the relationships between asthma symp-
toms, diagnostic labelling, and treatment in a cohort of Shef-
field children, and investigated the different patterns observed
in areas of varying socioeconomic deprivation to test the
hypothesis that asthma symptoms and health behaviour
related to asthma might vary with degree of deprivation.
METHODS
As previously described, we surveyed a single school year of
Sheffield schoolchildren aged 8–9 years in 1999 using a parent
respondent survey based on the International Survey of Asthma
and Allergies in Childhood (ISAAC) questions.3 Information
obtained included history ofwheeze ever,wheeze frequency and
severity in the previous 12 months, sleep disturbance due to
cough and wheeze, cough frequency, exertional cough or
wheeze, and “chestiness” with colds and breathlessness.
Additional questions obtained information about eczema and
hayfever and drug medication and whether the child had a cur-
rent diagnosis of asthma. Respondents were asked to give
details of specific drug medication taken for chest problems.
All schools with pupils aged 8–9 years were approached and
asked to provide a list of names for all pupils in year 4 (aged
8–9 years). Individually labelled questionnaires were distrib-
uted to schools with instructions for children to take them
home for their parents to complete. To increase the return rate,
non-responders were given a second identical questionnaire
after 2 weeks. Postcode data obtained from the questionnaire
were used to assign a Townsend score (derived from home and
car ownership, employment status, and household size
obtained from census data) to each respondent household
based upon electoral ward. Before analysing the responses to
the questionnaire, the 29 Sheffield electoral wards were
divided into five “deprivation quintiles” based on Townsend
score and each respondent was placed into the corresponding
group (1=least deprived, 2=below average deprived, 3=aver-
age, 4=above average deprived, 5=most deprived). Data were
stored in accordance with the Data Protection Act and were
analysed using the χ2 test for trend. The study was approved by
the South Sheffield research ethics committee and the
Sheffield Education Authority.
RESULTS
5011/6021 (83.2%) questionnaires were returned. 156/5011
respondents (3.1%) did not wish to take part in the survey.
Postcode data were available in 4353/4855 remaining replies
(89.7%). The number of replies where postcode data were avail-
able for least deprived, below average, average, above average,
and most deprived groups were 1098, 942, 761, 833, and 719,
respectively.
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Asthma diagnosis and symptom severity
Increasing deprivation was significantly associated with the
prevalence of reported wheeze ever, wheeze in the previous 12
months, asthma ever, and current asthma (defined by a posi-
tive answer to the question “does your child have asthma at
present?”) (table 1). Significant positive trends were also
observed for “significant asthma symptoms” (arbitrarily
defined as the presence of one or more of the following
reported symptoms: wheeze attacks >4/year, nocturnal
wheeze or cough at least once a week, cough and/or wheeze
symptoms “most times” with exertion), and undiagnosed
asthma (defined as significant asthma symptoms in the
absence of a current diagnosis of asthma) (table 1).
Significant increases in symptom frequency and severity were
seen in more deprived areas despite considerable variation in
prevalence within the most deprived group. Night cough was
the symptom most highly correlated with deprivation (table
2). Interestingly, there was no significant difference in the
prevalence of significant symptoms (as defined above) within
the diagnosed asthmatic subjects across deprivation groups
(data not shown).
Diagnostic accuracy
We considered the proportion of children with “significant
asthma symptoms” (see above) who had a reported diagnosis
of current asthma to be an index of diagnostic pick up rate. In
the whole sample this proportion was 383/637 (60.1%), and
there was no significant association with deprivation quintile.
The converse of this—the proportion of children with reported
current asthma who did not have “significant asthma
symptoms”—was considered to be an index of overdiagnosis
rate and amounted to 82/583 (14.1%) with no significant
trend across deprivation quintiles (table 3).
Appropriateness of asthma treatment
Overall, 821/4047 (20.3%) of the sample were taking asthma
medication, with a slight but significant increase with
increasing deprivation quintile (table 3). In children with sig-
nificant asthma symptoms 456/629 (72.3%) reported taking
asthma medication. When analysed by deprivation group no
significant trendwas observed (χ2 for trend= 0.59,NS),which
suggests that there were no differences in the prevalence of
appropriately treated children between groups. In addition,
there was no significant trend in the use of asthmamedication
in children reporting current asthma and significant asthma
symptoms (table 3). However, there were significant negative
trends in the prevalence of children with undiagnosed asthma
receiving (appropriate) asthma medication, and children with
no objective symptoms plus no current asthma diagnosis
receiving asthma medication which is presumably inappropri-
ate (table 3). These data suggest that children living in areas of
least deprivation are more likely to receive asthmamedication,
both in the absence of a diagnosis of asthma and in the
absence of symptoms of asthma.
Table 1 Asthma diagnosis and symptom prevalence across deprivation quintiles
Deprivation quintile
1 (least) 2 3 4 5 (most) χ2 for trend
Asthma ever 290/1090 (26.4%) 274/936 (29.4%) 241/753 (31.9%) 277/825 (33.5%) 230/711 (32.0%) 10.9 (p<0.001)
Odds ratio (95% CI) 1 1.14 (0.94 to 1.39) 1.30 (1.06 to 1.59) 1.39 (1.15 to 1.70) 1.32 (1.07 to 1.62)
Current asthma 110/1090 (10.0%) 120/935 (12.7%) 108/756 (14.4%) 134/821 (16.2%) 111/709 (15.4%) 16.9 (p<0.001)
Odds ratio (95% CI) 1 1.31 (1.00 to 1.73) 1.49 (1.12 to 1.97) 1.74 (1.33 to 2.28) 1.65 (1.25 to 2.19)
Wheeze ever 362/1093 (33.0%) 338/936 (36.4%) 289/754 (38.6%) 317/825 (38.7%) 269/708 (38.1%) 7.1 (p<0.01)
Odds ratio (95% CI) 1 1.14 (0.95 to 1.37) 1.26 (1.03 to 1.52) 1.26 (1.04 to 1.52) 1.24 (1.02 to 1.51)
Wheeze in previous 12 months 172/1091 (15.6%) 182/936 (19.6%) 178/753 (23.9%) 169/823 (20.7%) 170/708 (24.3%) 19.9 (p<0.001)
Odds ratio (95% CI) 1 1.29 (1.03 to 1.62) 1.65 (1.31 to 2.10) 1.38 (1.09 to 1.75) 1.69 (1.33 to 2.14)
“Significant asthma symptoms”* 102/1098 (9.3%) 116/942 (12.3%) 138/761 (18.1%) 153/833 (18.4%) 140/709 (19.7%) 38.7 (p<0.001)
Odds ratio (95% CI) 1 1.37 (1.04 to 1.82) 2.16 (1.64 to 2.85) 2.20 (1.68 to 2.88) 2.40 (1.83 to 3.16)
Undiagnosed asthma** 35/1090 (3.2%) 40/935 (4.3%) 55/756 (7.3%) 60/821 (7.3%) 64/709 (9.0%) 30.6 (p<0.001)
Odds ratio (95% CI) 1 1.35 (0.85 to 2.14) 2.37 (1.53 to 3.65) 2.38 (1.55 to 3.64) 2.99 (1.96 to 4.57)
Figures given as number/denominator (%).
*Defined by the presence of one or more of the following reported symptoms, irrespective of diagnostic label: wheeze attacks >3/year; nocturnal wheeze or cough at least once a
week; cough and/or wheeze symptoms “most times” with exertion.
**Defined as significant asthma symptoms in the absence of a current asthma diagnosis.
Table 2 Severity of asthma symptoms and treatment across deprivation quintiles
Deprivation quintile
1 (least) 2 3 4 5 (most) χ2 for trend
Wheeze attacks >3 per year 52/1087 (4.8%) 66/931 (6.9%) 78/750 (10.7%) 66/813 (8.3%) 68/700 (9.6%) 16.8 (p<0.001)
Odds ratio (95% CI) 1 1.52 (1.04 to 2.21) 2.31 (1.61 to 3.32) 1.76 (1.21 to 2.56) 2.14 (1.47 to 3.11)
Night wheeze >1/week 32/1088 (3.1%) 40/928 (4.3%) 59/745 (7.9%) 55/812 (6.5%) 52/700 (7.7%) 22.8 (p<0.001)
Odds ratio (95% CI) 1 1.49 (0.93 to 2.39) 2.84 (1.83 to 4.41) 2.40 (1.54 to 3.74) 2.65 (1.69 to 4.16)
Night cough >1/week 47/1089 (4.3%) 62/932 (6.7%) 75/759 (9.9%) 92/819 (11.3%) 88/708 (12.6%) 50.7 (p<0.001)
Odds ratio (95% CI) 1 1.58 (1.07 to 2.33) 2.43 (1.67 to 3.55) 2.81 (1.95 to 4.04) 3.15 (2.18 to 4.55)
Speech limiting wheeze 21/1089 (1.6%) 26/927 (2.7%) 33/743 (4.2%) 22/810 (2.6%) 16/695 (2.4%) 1.56 (NS)
Odds ratio (95% CI) 1 1.47 (0.82 to 2.63) 2.36 (1.36 to 4.12) 1.42 (0.78 to 2.60) 1.20 (0.62 to 2.31)
Figures given as number/denominator (%); NS=no significant difference.
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Atopic conditions
A significant negative trend across quintiles was seen for
eczema (current or “used to have”), although exact symptoms
were not asked for, with a prevalence of 33.9%, 31.5%, 34.4%,
27.9%, and 26.7% for groups 1–5, respectively (χ2 for
trend=12.62, p<0.001). No significant trend was observed for
reported hayfever.
DISCUSSION
We have studied the association between asthma morbidity
and socioeconomic deprivation in a large cohort of schoolchil-
dren in the same school year in the city of Sheffield. There
were significant positive trends in prevalence across depriva-
tion groups for current asthma, current wheeze, wheeze
attacks, and nocturnal symptoms. The greatest trend was
observed for nocturnal cough.
Studies relating socioeconomic measures and asthma have
suggested that composite deprivation scores are a good proxy
for morbidity.4 By assigning Townsend scores by electoral ward
area, we have assumed that everyone within a specific
electoral ward is equally deprived.
Children in the same school year in all primary schools in
Sheffield were surveyed and a good overall response rate was
obtained. In the subgroup where postcode data were available,
the questionnaire response rate was greatest from the least
deprived and lowest from the most deprived groups. While
this may represent behavioural differences across socioeco-
nomic groups which could affect the validity of the results, the
sample size from each deprivation group is large. Ethnic
minority groups tend to be over-represented in less deprived
groups. We did not translate questionnaires into non-English
languages as this did not affect the overall return rate of ques-
tionnaires in a school survey performed in Sheffield in 1991,5
nor did we follow up all non-respondents. Although this may
have biased the results, it is unlikely to have caused the varia-
tions seen with deprivation unless a complex interaction
between deprivation, health behaviour, and questionnaire
response is postulated. In a study of New Zealand adults Sal-
mond et al6 observed that asthma prevalence associated with
deprivation at an area level was unlikely to be attributable to
study biases and confounding factors including ethnicity.
Our study has shown that the prevalence and severity of
asthma increase with worsening socioeconomic deprivation,
as measured by Townsend score at electoral ward level. A
number of previous reports have found lower socioeconomic
status to be associated with increased reported wheeze,7–9
while other studies have not.10–13 Other factors such as health
care utilisation, medication use, and asthma diagnosis rates
are undoubtedly linked to social class. Anderson11 found that
asthma medication usage was associated with social class,
although wheeze prevalence was not. Poorer families are more
likely to use emergency services for asthma and to require
admission during attacks,14–17 and some authors have found
that severe asthma appears more common in poorer
families.18 Although we found more frequent symptoms to be
commoner inmore deprived areas, themost severe indicator—
speech limiting wheeze—was not affected by deprivation.
Maternal reporting behaviour may also vary across social
class. A further potential confounding influence on question-
naire based studies is the finding that poorer mothers were
more likely to report a diagnosis of asthma in a child in the
absence of a diagnosis in the medical records.19 Nevertheless,
objective measures such as exercise induced bronchospasm
have been shown to be more prevalent in children from lower
socioeconomic backgrounds.10
Nocturnal cough was the symptom for the whole popula-
tion which was most strikingly related to deprivation. Not all
nocturnal cough is due to asthma, and previous studies in
Italy, Canada and the UK have found cough to be the respira-
tory symptom most strongly related to socioeconomic
deprivation.8 10 12 Clearly poverty per se does not cause the res-
piratory morbidity, but the mechanism by which deprivation
might cause respiratory symptoms is uncertain. Interestingly,
allergic sensitisation appears to decrease with increasing pov-
erty level.20 Possible explanations for the deprivation related
differences include differences in parental smoking, variation
in housing conditions, or reporting or medication behaviour.
We did not collect data on parental smoking habits or housing,
so cannot comment on the most likely mechanism in our
population. It has been reported previously that smoking
prevalence, particularly in mothers, is strongly associated with
Townsend score, and children from smoking households have
an increased risk of most respiratory symptoms,21 particularly
in more deprived families,22 so it is likely to be a contributing
factor to our findings.
Duran-Tauleria et al23 in a national cross sectional study per-
formed in 1990 in children aged 5–11 years suggested that the
risk of underdiagnosis and undertreatment of asthma was
higher in children from ethnic minority groups in English
inner city areas. Socioeconomic factors may also be important
in adherence to treatment,24 subsequently determining
whether or not persisting symptoms are reported. In our study
there was a positive trend in reported medication usage from
least to most deprived groups, probably as a result of the
increased symptomatology observed. There was no evidence
Table 3 Concordance of asthma diagnosis, asthma symptoms, and treatment across deprivation quintiles
Deprivation quintiles
1 (least) 2 3 4 5 (most) χ2 for trend
“Diagnostic pick up” (diagnosed asthma
in those with significant symptoms*)
63/98 (64.3%) 76/116 (65.5%) 81/136 (59.6%) 90/150 (60.0%) 73/137 (53.3%) 0.98 (NS)
Odds ratio (95% CI) 1 1.06 (0.6 to 1.85) 0.82 (0.48 to 1.40) 0.83 (0.49 to 1.41) 0.63 (0.37 to 1.08)
“Overdiagnosis” (no significant asthma
symptoms* but current asthma
diagnosis)
20/110 (18.2%) 12/120 (10.0%) 8/108 (7.4%) 27/134 (20.1%) 15/111 (13.5%) 0.04 (NS)
Odds ratio (95% CI) 1 0.50 (0.23 to 1.08) 0.36 (0.15 to 0.86) 1.14 (0.6 to 2.16) 0.70 (0.34 to 1.46)
Asthma treatment (any) 191/1044 (18.3%) 171/886 (19.3%) 158/717 (22.0%) 158/747 (21.2%) 143/653 (21.9%) 4.79 (p<0.01)
Odds ratio (95% CI) 1 1.07 (0.85 to 1.34) 1.26 (1.0 to 1.60) 1.20 (0.95 to 1.52) 1.25 (0.98 to 1.60)
Asthma treatment in undiagnosed
asthmatics with significant symptoms*
23/34 (67.6%) 18/40 (45.0%) 21/53 (39.6%) 11/34 (32.4%) 16/34 (47.1%) 8.95 (p<0.01)
Odds ratio (95% CI) 1 0.39 (0.15 to 1.01) 0.31 (0.13 to 0.75) 0.23 (0.08 to 0.63) 0.43 (0.16 to 1.14)
Asthma treatment despite no significant
symptoms* or current asthma diagnosis
78/938 (8.3%) 53/768 (6.9%) 37/586 (6.3%) 31/607 (5.1%) 31/520 (6.0%) 4.82 (p<0.05)
Odds ratio (95% CI) 1 0.82 (0.57 to 1.17) 0.74 (0.50 to 1.11) 0.59 (0.39 to 0.91) 0.70 (0.45 to 1.08)
Figures given as number/denominator (%); NS=no significant difference.
*Defined by the presence of one or more of the following reported symptoms, irrespective of diagnostic label: wheeze attacks >3/year; nocturnal wheeze or cough at least once a
week; cough and/or wheeze symptoms “most times” with exertion.
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that undertreatment in the more deprived groups was
responsible for the increased symptom prevalence.
Our study examined the prevalence of underdiagnosis in
children with significant asthma symptoms and overdiagnosis
in children diagnostically labelled as having asthma but with-
out significant objective symptoms.We interpreted these rates
to represent diagnostic accuracy and found no significant dif-
ferences across deprivation groups. When treatment with
asthma medication was examined, there was a significant
positive trend from least to most deprived groups which mir-
rored trends in current asthma diagnosis and asthma
symptoms. The opposite observed trend for children with
undiagnosed asthma receiving appropriate treatment
suggests that there may be differences in diagnostic labelling
behaviour between deprivation groups. We found that, in
areas with the lowest deprivation scores, children with asthma
symptoms and receiving medication are less likely to be
labelled as asthmatic, and children with no significant symp-
toms of asthma are more likely to receive unnecessary asthma
treatment. We believe that our study is the first to observe
socioeconomic differences in diagnostic labelling behaviour in
childhood asthma.
This study has shown that asthma morbidity and diagnosis
increase with increasing level of socioeconomic deprivation,
without a general increase in atopic disease. No significant
differences were found in diagnostic accuracy between depri-
vation groups.However, our findings that, in the least deprived
areas, children on asthma medication are less likely to be
labelled as having asthma and children without significant
asthma symptoms are more likely to be on inappropriate
medication suggest differences in drug prescribing and
diagnostic labelling behaviour between deprivation groups.
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